Leslie, L., Musuraca, G., Abrisqueta, P., Brody, J., Christensen, J., Fosså, A., Poel, M. V. D., Vermaat, J., Offner, F., Belada, D., Mei, J., Altintas, I., Risum, M., Reilly, A., Wang, L., Falchi, L. (2025). Epcoritamab with rituximab + lenalidomide (R2) and epcoritamab maintenance deliver deep and durable remissions in previously untreated (1L) follicular lymphoma (FL): 3-year outcomes from epcore NHL-2 arms 6 and 7. Blood. https://doi.org/10.1182/blood-2025-465